Programming - Hypertension Scientific Sessions

American Heart Association Presidential Remarks
Manesh Patel, MD, FAHA

Welcome Remarks
Jane F. Reckelhoff, PhD, FAHA | Chair, Council on Hypertension
Steven D. Crowley, MD | Chair, Hypertension 2026 Scientific Sessions Program Committee

Metabolic Reprogramming via HIF-1α to Confront Kidney and Cardiovascular Disease
Volker Haase, MD

HIF-2α inhibition and Pheochromocytoma/Paraglioma
Camilo Jimenez Vasquez, MD

Recent Clinical Trials
Jamie Dwyer, MD

Mechanisms for disrupting aldosterone signals to afford protection in hypertension and CVD
David Ellison, MD

Imaging macula densa function in blood pressure regulation
Janos Peti-Peterdi, MD, PhD

The macula densa’s role in mechanisms of AKI and resulting CKD
Ruisheng Liu, MD, PhD

3:30 – 4:30
7C1: Beyond the Cuff: Wearables and Next-Generation BP Monitoring Technologies
Moderators: Gianfranco Parati, MD and Eugene Yang, MD, FACC

Unlocking Physiologic Signals: What Waveforms Reveal Beyond Blood Pressure
Rama Mukkamala, PhD

Smartwatches and Wearables: Consumer Tools for Hypertension Detection
Dean Picone, PhD

Navigating the FDA: Validation and Approval for Novel BP Measurement Devices
TBD

Panel discussion with Q and A
Panelists: Hae-Young Lee, PhD, Jordana B. Cohen, MD, MSCE, and Christine Chen, MD

4:30 – 5:30
7C2: Smarter Hypertension: Harnessing AI for Detection and Management
Moderators: Matthew Alexander, MD, PhD, FAHA and Tammy Brady, MD, PhD

Mining the EHR: Can We Identify Sub-phenotypes of Primary Hypertension?
Jaclyn Hall, PhD

Predicting Pediatric Hypertension: AI for Early Detection and Treatment
Derek Ng, PhD, ScM

Implementing AI to Improve Blood Pressure Management
Tina Ann Thompson, MD

Panel discussion with Q and A
Panelists: Paul Drawz, MD, MHS, MS and Gabriel Tajeu, DrPH, MPH

Basic and immune mechanisms of cognitive impairment in hypertension
Daniela Carnevale, PhD

Cerebral small vessel disease and dementia in human hypertension
Rebecca Gottesman, MD, PhD

Identifying patients who warrant screening for hormonally-driven hypertension in different clinical settings
Adina Turcu, MD, MS

How should we currently be thinking about subclinical primary aldosteronism and cortisol excess?
Greg Hundemer, MD, MPH

The current state of confirmatory testing and detecting lateralization in primary aldosteronism
Alexander Leung, MPH, MD, FRCPC

Genetic manifestations of hyperaldosteronism and hypercortisolism
Ashima Gulati, MD, PhD

Device development: from the oscillometric envelope to FDA clearance
Bruce Friedman, MD

Device prioritization for out-of-office measurement
Carissa Baker Smith, MD, MPH, MS, FAHA

Importance of the cuff for measurement accuracy: challenges with obesity, pediatric populations, and home devices
Speaker: Tammy Brady, MD, PHD

Standardized hypertension management algorithms: measurement, diagnosis, and prescription of SPC
Marc Jaffe, MD

Out-of-office BP integration and remote monitoring implementation
Sharon Rikin, MD, MS

Coverage changes, reimbursement landscape, and billing for home and remote BP
Kate Kirley, MD, MS

Strategy pathways
Hilary Wall, MPH

Birth history and its role in development of hypertension
Joseph Flynn, MD, MS

Youth hypertension and long-term CV and cognitive outcomes
Rahul Chanchlani, MD

Arterial characteristics across age continuum
Josh Samuels, MD, MPH

Sex differences in physiology and trajectory of blood pressure across the lifespan
Natalie Ann Bello, MD, MPH

Physiologic and pathologic changes in blood pressure during pregnancy
Janet Catov, PhD, MS

Role of behavioral psychologist: Coaching techniques to help with implementation of traditional and nontraditional lifestyle modifications
Kaushal Amatya, PhD

Role of the dietitian: Practical diet/salt strategies for hypertension management across the lifespan
Kristie Lancaster, PhD

Weight loss strategies with and without GLP-1RAs
Alexa Triot, MD

The effects of time-restricted feeding on cardiovascular disease in obesity
Jennifer Pollock, PhD

Key clinical research: Role of Circadian Regulation in Cardiometabolic Health and Disease Risk
Kristen Knutson, PhD

BMAL1, aldosterone, and sex differences in blood pressure regulation
Michelle Gumz, PhD

Renal denervation in complex patients
Jennifer Cluett, MD

Secondary hypertension in pregnancy
Lara Kovell, MD

Resistant hypertension without clear secondary cause
Brian Byrd, MS, MS

Hypertension management among older, frail adults
B. Gwen Windham, MD